A PHARMACEUTICAL FORMULATION CONTAINING RECOMBINANT HUMAN SERUM ALBUMIN-INTERFERON ALPHA FUSION PROTEIN

摘要

A pharmaceutical formulation contains recombinant human serum albumin-interferon alpha fusion protein (rHSA-IFNa). The pharmaceutical formulation comprises 0.1-5 mg/ml rHSA-IFNa and a stabilizing adjuvant of glycine or methionine dissolved in buffer solution having a pH of 5.0-8.0. The pharmaceutical formulation has storage stability.